Scott A. Kelly - Mar 31, 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CMO, Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Stock symbol
CYDY
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 04:08 PM
Previous filing
Oct 20, 2021
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +15.6K +0.81% $0.00 1.95M Mar 31, 2022 Direct F1
transaction CYDY Common Stock Award $0 +21.4K +1.1% $0.00 1.97M Apr 15, 2022 Direct F1
transaction CYDY Common Stock Award $0 +18K +0.91% $0.00 1.99M Apr 30, 2022 Direct F1
transaction CYDY Common Stock Award $0 +17K +0.85% $0.00 2.01M May 15, 2022 Direct F1
transaction CYDY Common Stock Award $0 +18K +0.9% $0.00 2.03M May 31, 2022 Direct F1
holding CYDY Common Stock 782K Mar 31, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Remarks:

EX 24 - Power of Attorney